ArticleJapanese journal of clinical oncology2012

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial.

Tetsuhide Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.